Abstract
Epstein–Barr virus-encoded small RNA (EBER) is nonpolyadenylated, noncoding RNA, forms stem-loop structure by intermolecular base-pairing giving rise to double-stranded RNA (dsRNA)-like molecule and exists abundantly in EBV-infected cells. EBER induces IL-10 and thus supports the growth of Burkitt's lymphoma (BL) cells. In this study, the mechanism of IL-10 induction by EBER was analysed in the context of dsRNA signaling pathway. Knockdown of retinoic acid-inducible gene I (RIG-I) by small interfering RNA (siRNA), and expression of dominant-negative RIG-I downregulated IL-10 induction in EBER(+) EBV-infected and EBER plasmid-transfected BL cells. Transfection of EBER-expressing plasmid or in vitro synthesized EBER induced IL-10 in RIG-I-expressing cell clones, and activation of IL-10 promoter by EBER was blocked by dominant-negative RIG-I. Blocking of nuclear factor (NF)-κB by dominant-negative IκB-α plasmid did not block IL-10 expression, whereas knockdown of IRF-3 by siRNA resulted in downregulation of IL-10 in EBER(+) BL cells. NF-κB is reported to function downstream of RIG-I signaling pathway and is involved in the induction of proinflammatory cytokines. Our results indicate that EBER induces an anti-inflammatory cytokine IL-10 through RIG-I-mediated IRF-3 but not NF-κB signaling. These findings suggest a new mechanism of dsRNA signaling pathway that triggers the expression of IL-10, which acts as an autocrine growth factor in BL cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arrand JR, Young LS, Tugwood JD . (1989). Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 63: 983–986.
Clarke PA, Schewemmle M, Schickinger J, Hilse K, Clemens MJ . (1991). Binding of Epstein-Barr virus small RNA EBER-1 to the double stranded RNA-activated protein kinase DAI. Nucleic Acids Res 19: 243–248.
de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, teVelde A, Figdor C et al. (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174: 915–924.
de Waal Malefyt R, Yssel H, de Vries JE . (1993). Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 15: 4754–4765.
Glickman JN, Howe JG, Steitz JA . (1988). Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62: 902–911.
Gregory CD, Rowe M, Rickinson AB . (1990). Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71: 1481–1495.
Heitbrock LZ, Lotzerich M, Schaefer A, Werner T, Frankenberger M, Benkhart E . (2003). IFN-α induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J Immunol 171: 285–290.
Imaizumi T, Yagihashi N, Hatakeyama M, Yamashita K, Ishikawa A, Taima K et al. (2004). Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with IFN-γ. Life Sci 75: 1171–1180.
Iwakiri D, Eizuru Y, Tokunaga M, Takada K . (2003). Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res 63: 7062–7067.
Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K . (2005). Epstein-Barr virus-encoded small RNA induces insulin-like growth factor1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24: 1767–1773.
Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K et al. (2005). Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19–28.
Kieff E, Rickinson AB . (2001). Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds). Fields Virology, 4th edn. Lippincott Williams & Wilkins: Philadelphia, PA, pp 2511–2573.
Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T et al. (2000). Epstein-Barr virus-encoded poly(A)− RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 19: 6742–6750.
Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P . (1968). Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 28: 1300–1310.
Komano J, Maruo S, Kurozumi K, Oda T, Takada K . (1999). Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 73: 9827–9831.
Lerner MR, Andrews NC, Miller G, Steitz JA . (1981). Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78: 805–809.
Lin R, Heylbroeck C, Genin P, Pitha P M, Hiscott J . (1999). Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 19: 959–966.
Mitchell T, Sugden B . (1995). Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 69: 2968–2976.
Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG . (1994). The Epstein-Barr virus latent membrane protein-1 (LMP-1) induces interleukin-10 production in Burkitt's lymphoma cells. Int J Cancer 57: 240–244.
Nanbo A, Inoue K, Adachi-Takasawa K, Takada K . (2002). Epstein-Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt's lymphoma. EMBO J 21: 954–965.
Rickinson AB, Kieff E . (2001). Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds). Fields Virology, 4th edn. Lippincott Williams & Wilkins: Philadelphia, PA, pp 2575–2627.
Rosa MD, Gottlieb E, Lerner MR, Steitz JA . (1981). Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus associated ribonucleic acids VAI and VAII. Mol Cell Biol 1: 785–796.
Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT . (2000). Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 74: 10223–10228.
Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K . (2006). EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 25: 4207–4214.
Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, Proud CG et al. (1993). Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res 21: 4483–4490.
Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K . (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68: 6069–6073.
Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M et al. (1991). An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5: 147–156.
Toczyski DP, Matera AG, Ward DC, Steitz JA . (1994). The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci USA 91: 3463–3467.
Toczyski DP, Steitz JA . (1991). EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBER). EMBO J 10: 459–466.
Tone M, Powel MJ, Tone Y, Thompson AJS, Waldmann H . (2000). IL-10 expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 165: 286–291.
Wagoner J, Austin M, Green J, Imaizumi T, Casola A, Brasier A et al. (2007). Regulation of CXCL-8 (Interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol 81: 309–318.
Wu Y, Maruo S, Yajima M, Kanda T, Takada K . (2007). Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol 81: 11236–11245.
Yajima M, Kanda T, Takada K . (2005). Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 79: 4298–4307.
Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N, Yamamoto N . (2000). Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett 484: 153–158.
Yang L, Aozasa K, Oshimi K, Takada K . (2004). Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV infected T cells through interleukin 9 induction. Cancer Res 64: 5332–5337.
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M et al. (2004). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730–737.
Acknowledgements
We thank S Maruo, T Kanda and H Yoshiyama for helpful discussions and Y Ando for technical assistance. This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samanta, M., Iwakiri, D. & Takada, K. Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27, 4150–4160 (2008). https://doi.org/10.1038/onc.2008.75
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.75
Keywords
This article is cited by
-
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
Journal of Translational Medicine (2023)
-
Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis
Annals of Hematology (2023)
-
Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA
Nature (2022)
-
Cellular origins of dsRNA, their recognition and consequences
Nature Reviews Molecular Cell Biology (2022)
-
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
Journal of Experimental & Clinical Cancer Research (2021)